Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study.
Xiaoying KangAlexander PlonerNancy L PedersenSara Bandres-CigaAlastair J NoyceKarin WirdefeldtDylan M WilliamsPublished in: Neurology (2021)
This study provides Class II evidence that TNF-TNFR1 signaling inhibition is not associated with the risk or age at onset of PD.